michigan semaglutide intestinal paralysis class action Ozempic, Mounjaro manufacturers sued over claims of "stomach paralysis" side effects kentucky semaglutide intestinal paralysis law

Not all individuals will experience the same level of weight loss, and success depends on multiple factors including adherence to treatment, lifestyle modifications, and individual metabolic factors.

Food and Drug Administration (FDA) allows people to report product issues with medication to the Adverse Event Reporting System (FAERS)

Peptide therapy uses peptides to communicate and direct cells to perform the functions specific to those peptides

Womens Dermatol 5 (5), 285307

50% reduction in drug-related deaths 40% fewer overdoses 30% fewer emergency department visits 25% fewer hospitalizations In practical terms, that translates to seven fewer new SUD diagnoses and 12 fewer serious harm events per 1,000 GLP-1 users

So were just getting hosed in the U S